<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-OGPDJLJB</identifier><date>2014</date><creator>Su, Yu-Li</creator><relation>documents/doc/O/URN_NBN_SI_doc-OGPDJLJB_001.pdf</relation><relation>documents/doc/O/URN_NBN_SI_doc-OGPDJLJB_001.txt</relation><format format_type="issue">3</format><format format_type="volume">48</format><format format_type="type">article</format><format format_type="extent">str. 314-322, VII</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">276622080</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-OGPDJLJB</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">breast</subject><subject language_type_id="slv">dojke</subject><subject language_type_id="slv">mastektomija</subject><subject language_type_id="slv">radioterapija</subject><subject language_type_id="slv">rak (medicina)</subject><title>Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1-3 axillary lymph node(s) metastases</title></Record>